Accremeter

ACCREMeter empowers chronic kidney disease (CKD) patients with real-time insights into their kidney function, enabling early lifestyle changes — such as diet adjustment — to slow disease progression and improve health outcomes. Our compact, handheld device delivers accurate, immediate creatinine measurements directly to patients, using a novel patented chemical method offering superior selectivity compared to traditional lab-based tests. Unlike today's delayed laboratory testing, ACCREMeter puts continuous kidney health monitoring in the hands of patients, supporting proactive care long before dialysis becomes necessary. Chronic kidney disease affects over 850 million people worldwide, and the annual cost of end-stage renal disease (ESRD) in the U.S. healthcare system exceeds $100 billion. Early intervention solutions are critically needed to reduce this burden and extend quality of life